Join the forefront of groundbreaking research at City of Hope, where we are changing lives and making a meaningful impact in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are united by a shared mission: to contribute to innovative approaches that predict, prevent, and cure disease while helping shape the future of medicine through cutting-edge research.
The Dr. Jeff Perry laboratory in the Beckman Research Institute of City of Hope is seeking a highly motivated postdoctoral fellow to join a multidisciplinary drug discovery program focused on a metabolic enzyme that plays a central role in cholesterol homeostasis and bile acid synthesis, with direct implications for metabolic disease and cardiometabolic risk.
As a successful candidate, you will:
Lead efforts in recombinant protein expression and purification, and structure determination using X-ray crystallography to enable structure-guided ligand design.
Collaborate at the interface of structural biology, chemical biology, and translational therapeutics, contributing to the development of first-in-class modulators targeting a clinically relevant metabolic pathway.
Your qualifications should include:
Ph.D. in life sciences, biomedical sciences, or a related discipline is required.
Prior experience in protein biochemistry and X-ray crystallography is essential.
Experience in quantitative biophysical characterization of small-molecule binding studies such as SPR, ITC, and DSF and/or an interest in mechanism-driven drug discovery and fragment-based approaches is highly desirable.
Proven track record of successful research projects and publications.
Excellent analytical and problem-solving skills.
Effective communication and collaboration abilities.
City of Hope employees pay is based on the following criteria: work experience, qualifications, and work location.
City of Hope is an equal opportunity employer.
To learn more about our Comprehensive Benefits, please CLICK HERE.
#PD